Establishes GEP as the preferred partner for companies transforming procurement to mitigate inflation, drive value and sustainability
Quadrant Knowledge’s SPARK Matrix™ is latest study to name GEP ahead of global consulting and technology conglomerates, citing the company’s superior customer impact and service excellence
CLARK, N.J., Sept. 21, 2022 /PRNewswire/ — GEP®, a leading provider of procurement and supply chain strategy, software and managed services to Fortune 500 and Global 2000 enterprises worldwide, has been named Leader in Quadrant Knowledge’s SPARK Matrix™: Procurement Services 2022 report, citing the firm’s superior “customer impact” and “service excellence.” This report evaluates providers of procurement consulting services as well as the software platforms and tools enterprises use to transform procurement and conduct real-time analysis of procurement activities and related data. SPARK Matrix™ is the third analyst assessment in 2022 to name GEP as a Leader in procurement services, establishing the company as the industry’s preferred global solution provider.
Go to http://gep.com/procurement-leader to download a complimentary copy of each of the three research reports:
Quadrant Knowledge – SPARK Matrix™: Procurement Services 2022
Everest Group – Procurement Outsourcing Service Providers PEAK Matrix™ 2022
ISG Provider Lens™ – 2022 Procurement BPO and Transformation Services, Enterprise (Global) and Mid Markets (Global)
“At a time when companies are transforming their procurement operations to fight inflation, increase supplier diversity and drive sustainability, we’re proud to be the clear industry leader and preferred partner,” said Al Girardi, GEP’s global head of marketing. “We’re even more excited about the future because we uniquely combine more than two decades of providing services with our proprietary AI-driven software, to drive our clients’ competitive advantage. We are going to continue to lead the transformation of procurement from back-office to strategic function, for our clients to improve shareholder value.”
Explaining the selection of GEP, Quadrant Knowledge stated: “GEP helps organizations attain their strategic, operational, and financial objectives by leveraging a pool of strategic procurement consulting services, managed services, and a source-to-pay procurement platform.” Quadrant Knowledge’s 2022 assessment named GEP as Leader because of its:
Proprietary software platform: Market-leading procurement software platforms that GEP is constantly upgrading
Comprehensive supply chain and procurement experience: Providing clients with comprehensive procurement services
Multiple verticals and regional expertise: GEP provides deep expertise in more than 11 industries through its presence in North America, Europe, Asia-Pacific, and the Middle East
Sustainability and resilience: Focus on helping clients’ achieve supply chain sustainability and resilience goals
About Quadrant Knowledge Solutions
Quadrant Knowledge Solutions is a global advisory and consulting firm focused on helping clients in achieving business transformation goals with Strategic Business and Growth advisory services. At Quadrant Knowledge Solutions, their vision is to become an integral part of their client’s business as a strategic knowledge partner. Their research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments. For more available research, please visit https://quadrant-solutions.com/market-research/.
About GEP
GEP® delivers transformative supply chain solutions that help global enterprises become more agile and resilient, operate more efficiently and effectively, gain competitive advantage, boost profitability and increase shareholder value.
Fresh thinking, innovative products, unrivaled domain expertise, smart, passionate people — this is how GEP SOFTWARE™, GEP STRATEGY™ and GEP MANAGED SERVICES™ together deliver supply chain solutions of unprecedented scale, power and effectiveness. Our customers are the world’s best companies, including hundreds of Fortune 500 and Global 2000 industry leaders who rely on GEP to meet ambitious strategic, financial and operational goals.
A leader in multiple Gartner Magic Quadrants, GEP’s cloud-native software and digital business platforms consistently win awards and recognition from industry analysts, research firms and media outlets, including Gartner, Forrester, IDC, ISG, and Spend Matters. GEP is also regularly ranked a top supply chain consulting and strategy firm, and a leading managed services provider by ALM, Everest Group, NelsonHall, IDC, ISG and HFS, among others.
Headquartered in Clark, New Jersey, GEP has offices and operations centers across Europe, Asia, Africa and the Americas. To learn more, visit www.gep.com.
Media Contact
Derek Creevey
Director, Public Relations
GEP
Phone: +1 732-382-6565
Email: derek.creevey@gep.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/its-a-triple-crown–gep-procurement-services-named-leader-by-3rd-market-analyst-report-in-2022-301629964.html
SOURCE GEP
Quarterly results suggest that some of the fears investors had about the lender's business were overblown.
After two decades of staying privately held, big-data analytics company Palantir Technologies (NYSE: PLTR) went public in Sept. 2020. While the company boasts several U.S. government agencies as well as brand-name commercial sector companies on its client roster, Wall Street has expressed concerns about Palantir's near-term growth rate. Palantir is off to a great start in 2023, and although some of the analyst concerns are valid, its valuation looks appealing for long-term investors.
In this article, we discuss 12 hot penny stocks on the rise. If you want to see more stocks in this selection, check out 5 Hot Penny Stocks On the Rise. Penny stocks usually trade under $5 and are favored by new investors or market participants who prefer day trading. Some key indicators that penny […]Huntington Bancshares (HBAN) delivered earnings and revenue surprises of 4.88% and 0.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Shares of Scilex Holding (NASDAQ: SCLX) were up 39.7% this week as of Thursday, according to data provided by S&P Global Market Intelligence. Scilex develops non-opioid treatments for acute and chronic pain. The healthcare company is majority owned by Sorrento Therapeutics, and there have been rumors of a potential buyout.
There are financial technology companies that are bringing innovation to consumers, but tougher credit markets have hurt their businesses. This could be an opportunity for long-term investors; these three stocks are poised to flourish when economic conditions ease up, so consider them before the bear market ends. Rapidly rising interest rates created two problems for Upstart Holdings (NASDAQ: UPST), which uses artificial intelligence to replace the traditional FICO credit score in approving consumer loans.
Macquarie Senior Media Tech Analyst Tim Nollen joins Yahoo Finance Live to discuss Netflix blowing past fourth-quarter earnings expectations, investor sentiment, subscriber growth, CEO Reed Hasting’s stepping down, and the expectations for Netflix in 2023.
In this article, we discuss 11 most undervalued auto stocks according to hedge funds. If you want to see more stocks in this selection, check out 5 Most Undervalued Auto Stocks According To Hedge Funds. The automotive industry has been plagued by multiple problems apart from the COVID-19 pandemic, such as the constrained Asia Pacific […]The latest update from an industry darling could signal big financial challenges for marijuana companies.
Novavax (NASDAQ: NVAX) is an investment that can look incredibly successful or awful depending on when you bought shares of the company. If it was during the early stages of the pandemic and before it developed its COVID-19 vaccine, you're sitting on some great profits. It has been a volatile stock to own, to say the least.
The stock market has thrown out MGM Resorts (NYSE: MGM), Verizon (NYSE: VZ), and Coinbase (NASDAQ: COIN) recently, but I think that's a mistake. The U.S. shutdowns didn't last long, but restrictions in Macao have lasted for nearly three years. As personal and business travel in the U.S. reopened, Las Vegas made a quick recovery.
Despite buyer protests in China over recent Tesla (TSLA) price cuts on the mainland, it seems the move overall has been a huge hit for the EV maker. Wedbush Securities conducted a survey of over 500 prospective EV buyers in China to gauge their reaction to Tesla’s price cuts. The results proved to be quite positive for Tesla’s prospects in the ultra-competitive EV market.
“I think all that's been a waste of time and why you guys waste any breath on it is totally beyond me,” Dimon told CNBC on Thursday. “Bitcoin itself is a hyped up fraud. It’s a pet rock.”
Before digital banking, people often had to visit a bank branch to do their banking. That meant opening a checking or savings account at whichever bank or credit union was in the neighborhood. Thus,…
Richard Edelman, CEO of one of the world's largest communications agencies, spoke out against Twitter at the World Economic Forum in Davos.
Healthcare stocks that struggled last year could be in for some relief. Now that there's less upheaval due to the pandemic, hospitals are resuming more normal operations, and that may mean better financial results — and potentially better returns for healthcare investors this year. An encouraging development suggests that brighter days could be ahead for stocks with exposure to hospitals, including Medical Properties Trust (NYSE: MPW) and HCA Healthcare (NYSE: HCA).
Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders.
The report by Redfin (RDFN) which tracked home-sale prices for the four weeks ending Jan. 15, found that the median price of a house in the U.S. rose 0.9% from a year ago, to $350,250. In San Francisco, prices fell 10.1% year-over-year, Redfin said. A drop in mortgage rates has prompted some buyers to rush in to the market.
Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.
You won’t even owe him a penny for his thoughts.
